PlenOptika is a Cambridge, Massachusetts medical device company that makes QuickSee, a handheld autorefractor that measures a person's eyeglass prescription in about ten seconds using wavefront aberrometry and machine-learning algorithms. Spun out of the Madrid-MIT M+Vision fellowship in 2014, the company set out to close the gap on uncorrected refractive error, a problem affecting more than a billion people worldwide. Its portable, clinic-quality device has been used by vision professionals and NGOs on over 5 million patients in more than 45 countries - and even flew aboard SpaceX's Polaris Dawn mission as the first handheld autorefraction device used in space.
Shivang R. Dave is the co-founder and CEO of PlenOptika, a Cambridge, Massachusetts medical-device company behind QuickSee, a handheld autorefractor that measures eyeglass prescriptions in about 10 seconds using wavefront aberrometry. A bioengineer with a PhD in bioengineering and nanotechnology, Dave co-invented the device during the Madrid-MIT M+Vision fellowship and has grown PlenOptika from a four-fellow research team into an international company whose technology has helped correct vision for over 7 million people across 60+ countries, especially in low-resource settings.